<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has submitted a letter to BSE dated April 30, 2025, stating that the company does not qualify as a 'Large Corporate' under SEBI's framework (circulars dated November 26, 2018 and October 19, 2023) governing fund raising through debt securities by large entities. Because the company falls below the Large Corporate threshold, it is not obligated to file any disclosure under the said circular. The letter is signed by Mr. Sohan Chaturvedi, Whole Time Director & CFO (DIN: 09629728). This is essentially a routine negative disclosure confirming non-applicability rather than any new action.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that Genpharmasec does not meet the Large Corporate criteria defined by SEBI, meaning no additional borrowing or debt-security-related disclosures apply.